Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.470 | None | 1.000 | 0 | 8 | 1999 | 2016 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.410 | None | 1.000 | 1 | 4 | 2001 | 2016 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.310 | None | 1.000 | 3 | 0 | 2004 | 2011 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2004 | 2015 | ||||||||
|
baculoviral IAP repeat containing 5 | 0.495 | 0.731 | 5.6E-02 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2015 | ||||||||
|
Wnt family member 2 | 0.569 | 0.615 | 1.8E-02 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2014 | ||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.510 | None | 1.000 | 0 | 0 | 2005 | 2005 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
retinoic acid receptor beta | 0.478 | 0.846 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2009 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2007 | 2015 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 1 | 2 | 2008 | 2016 | ||||||||
|
CLPTM1 like | 0.551 | 0.654 | 4.4E-05 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
ERCC excision repair 1, endonuclease non-catalytic subunit | 0.445 | 0.846 | 1.6E-07 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
YY1 transcription factor | 0.481 | 0.808 | 0.99 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
POU class 4 homeobox 1 | 0.628 | 0.500 | 0.89 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
apolipoprotein B mRNA editing enzyme catalytic subunit 3B | 0.547 | 0.731 | 5.2E-16 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
major histocompatibility complex, class II, DP beta 2 (pseudogene) | 0.743 | 0.500 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | |||||||||
|
Wnt family member 5A | 0.443 | 0.808 | 0.99 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2015 | ||||||||
|
hes family bHLH transcription factor 1 | 0.468 | 0.885 | 0.71 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
protein inhibitor of activated STAT 3 | 0.608 | 0.500 | 0.98 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
notch receptor 2 | 0.441 | 0.808 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 |